Company Events

Company Dynamics

04-29

2022

Focus on the target and implement Agile target management through OKR

In recent years, Dorra’s business type has expanded and business scale has increased rapidly, the strategic development path of the company is clear, and the upgrading of the company's business model is gradually imp……

09-25

2020

【A Good Book】 Reading & sharing series activities -- Share of impression after reading 《Your first leadership job》

Reading a good book is like making a good friend, the longer the time goes by, the deeper the friendship will be.At the end of July, the second phase of the reading and sharing activities has been launched inside of Dorr……

07-27

2020

Connect with heart - New staff communication meeting

In order to enhance the communication, to promote the growth and to help the integration of new employees, the HR department of Dorra Pharma decided to build a communication platform for everyone, on July 2, Dorra Pharma……

04-06

2020

Rybelsus? (oral semaglutide) approved for the treatment of adults with type 2 diabetes in the EU

4 April 2020 - Novo Nordisk today announced that the European Commission (EC) has granted marketing authorisation for Rybelsus? (oral semaglutide), for the treatment of adults with insufficiently controlled type 2 diabet……

03-29

2020

ViiV Healthcare announces first global regulatory approval of CABENUVA; the first complete, long-acting, regimen for the treatment of HIV

March 20, 2020--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has approved CABENUVA, the first and onl……

03-06

2020

To win the battle against Corona virus, Dorra is on the way.

A sudden epidemic affected all the people nationwide, who made every preparation for the war in this war without smoke.It’s Dorra’s responsibility to fight with the epidemic when it occurred. Dow Pharmaceutical uses inte……

< 1 2 3 4 5 >

Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1